Therefore, the high levels of PAI-1 might inhibit the tPA/plasminogen system and inhibit cleavage of proBDNF, resulting in impaired BDNF signalling, which could result in reduced neural plasticity in the medial prefrontal cortex circuits in depression. Here, PLG is linked to depressive symptom measurement.